— Know what they know.
Not Investment Advice

SRTS NASDAQ

Sensus Healthcare, Inc.
1W: +1.4% 1M: -8.3% 3M: -2.3% YTD: -27.3% 1Y: -5.7% 3Y: +12.9% 5Y: -24.8%
$2.98
+0.03 (+1.02%)
 
Weekly Expected Move ±3.9%
$3 $3 $3 $3 $3
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 27 · $49.1M mcap · 14M float · 0.286% daily turnover · Short 12% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
30.7 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -47.6%  ·  5Y Avg: 11.2%
Cost Advantage ★
38
Intangibles
26
Switching Cost
28
Network Effect
29
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SRTS has No discernible competitive edge (30.7/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -47.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$4
Low
$5
Avg Target
$6
High
Based on 2 analysts since Aug 13, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 6Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.75
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-17 Industrial Alliance Securities Scott Henry $6 $6 -1 +89.0% $2.91
2026-08-14 Lake Street Ben Haynor Initiated $4 — +39.9% $2.86
2026-05-08 Industrial Alliance Securities — Initiated $6 — +58.2% $4.11
2026-02-17 Maxim Group Anthony Vendetti Initiated $6 — +53.5% $3.91
2024-05-13 H.C. Wainwright Raghuram Selvaraju $16 $10 -6 +79.9% $5.56
2022-05-06 H.C. Wainwright — Initiated $16 — +107.5% $7.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
Oct 02, 2026
DCF
3
ROE
1
ROA
1
D/E
2
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SRTS receives an overall rating of C+. Strongest factors: P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B- C+
2026-08-17 C- B-
2026-08-14 B- C-
2026-05-11 C+ B-
2026-04-01 B- C+
2026-02-13 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 24 Grade D
Profitability
10
Balance Sheet
84
Earnings Quality
38
Growth
12
Value
40
Momentum
20
Safety
100
Cash Flow
20
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SRTS scores highest in Safety (100/100) and lowest in Profitability (10/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
7.20
Safe Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-5.26
Unlikely Manipulator
Ohlson O-Score
-4.49
Bankruptcy prob: 1.1%
Low Risk
Credit Rating
A
Score: 74.7/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.44x
Accruals: -17.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SRTS scores 7.20, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SRTS scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SRTS's score of -5.26 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SRTS's implied 1.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SRTS receives an estimated rating of A (score: 74.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.18x
PEG
0.03x
P/S
2.80x
P/B
1.33x
P/FCF
-7.14x
P/OCF
—
EV/EBITDA
-3.67x
EV/Revenue
1.99x
EV/EBIT
-3.53x
EV/FCF
-5.01x
Earnings Yield
-31.15%
FCF Yield
-14.00%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. SRTS currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.219
NI / EBT
×
Interest Burden
1.285
EBT / EBIT
×
EBIT Margin
-0.565
EBIT / Rev
×
Asset Turnover
0.350
Rev / Assets
×
Equity Multiplier
1.126
Assets / Equity
=
ROE
-34.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SRTS's ROE of -34.8% is driven by Asset Turnover (0.350), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.22 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2.98
Median 1Y
$1.96
5th Pctile
$0.54
95th Pctile
$7.14
Ann. Volatility
83.3%
Analyst Target
$4.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Joseph C. Sardano
Chief Executive Officer
$600,000 $— $1,417,860
Michael Sardano President,
General Counsel, Chief Commercial Officer, & Corporate Secretary
$500,000 $153,200 $1,213,917
Javier Rampolla Financial
ancial Officer
$400,000 $— $752,710

CEO Pay Ratio

6:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,417,860
Avg Employee Cost (SGA/emp): $239,933
Employees: 60

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
60
+11.1% YoY
Revenue / Employee
$458,033
Rev: $27,482,000
Profit / Employee
$-128,650
NI: $-7,719,000
SGA / Employee
$239,933
Avg labor cost proxy
R&D / Employee
$129,633
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -0.9% 17.3% 67.7% 76.9% 78.9% 65.5% 14.2% 5.2% -2.0% 1.0% 9.5% 13.4% 18.9% 12.7% 3.5% -1.6% -5.7% -14.9% -15.8% -34.8% -34.83%
ROA -0.7% 13.7% 53.0% 60.7% 66.5% 54.5% 11.7% 4.4% -1.7% 0.9% 8.4% 12.1% 16.9% 11.5% 3.1% -1.4% -5.1% -13.4% -13.9% -30.9% -30.94%
ROIC -16.3% 35.2% 82.5% 1.1% 1.4% 54.5% 20.9% 6.5% -5.7% -1.1% 10.6% 17.2% 26.8% 17.3% 3.8% -3.5% -15.7% -30.5% -34.4% -47.6% -47.56%
ROCE -0.9% 15.7% 21.0% 30.4% 33.5% 31.0% 17.7% 5.6% -2.7% 0.3% 11.6% 17.0% 22.3% 14.4% 4.8% -2.6% -4.5% -14.6% -18.9% -26.8% -26.76%
Gross Margin 57.9% 68.0% 69.2% 68.3% 65.2% 63.7% 47.5% 57.9% 51.0% 62.3% 62.5% 58.7% 59.3% 54.4% 52.2% 39.7% 39.4% 38.4% 29.2% 33.6% 33.58%
Operating Margin 3.5% 40.8% 38.0% 37.8% 24.0% 31.8% -86.1% -24.9% -48.6% 44.4% 27.1% 21.5% 16.9% 13.2% -31.7% -26.6% -37.3% -63.8% -1.3% -1.4% -1.39%
Net Margin 3.5% 40.8% 1.6% 29.2% 20.3% 21.6% -55.5% -8.4% -37.2% 33.5% 21.3% 17.4% 13.7% 11.8% -30.8% -14.2% -13.7% -64.1% -77.4% -3.8% -3.82%
EBITDA Margin 5.8% 41.9% 38.9% 38.7% 26.1% 34.2% -83.9% -23.1% -37.6% 47.0% 28.2% 22.3% 18.1% 14.2% -30.0% -24.4% 9.0% -58.5% -1.2% -1.4% -1.35%
FCF Margin 4.9% -1.5% 11.1% 10.5% 15.1% -3.5% -28.7% -39.7% -60.8% -9.7% -14.6% -3.0% 5.1% -2.6% 11.7% 9.3% 6.1% 1.2% -3.3% -39.8% -39.76%
OCF Margin 5.9% -1.1% 11.4% 10.9% 15.6% -3.2% -27.9% -38.7% -59.8% -8.8% -13.7% -2.3% 6.4% -2.0% 11.8% 9.5% 5.4% 1.9% -2.4% -38.8% -38.83%
ROE 3Y Avg snapshot only -10.36%
ROE 5Y Avg snapshot only 5.97%
ROA 3Y Avg snapshot only -9.18%
ROIC 3Y Avg snapshot only -11.94%
ROIC Economic snapshot only -28.41%
Cash ROA snapshot only -16.48%
Cash ROIC snapshot only -30.87%
CROIC snapshot only -31.61%
NOPAT Margin snapshot only -59.82%
Pretax Margin snapshot only -72.53%
R&D / Revenue snapshot only 36.56%
SGA / Revenue snapshot only 75.55%
SBC / Revenue snapshot only 1.23%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -328.91 29.10 7.91 5.09 7.78 5.07 13.46 21.47 -50.30 79.17 13.33 13.10 10.18 17.12 42.97 -91.22 -17.06 -8.42 -8.43 -3.21 -3.178
P/S Ratio 3.11 4.43 4.91 3.12 4.68 2.76 2.25 1.70 1.81 1.57 1.96 2.39 2.30 2.72 1.96 2.06 1.44 2.36 2.91 2.84 2.802
P/B Ratio 2.88 4.61 3.97 2.84 4.41 2.56 1.83 1.11 1.01 0.79 1.21 1.65 1.75 2.04 1.46 1.49 1.00 1.35 1.44 1.35 1.331
P/FCF 63.19 -289.53 44.10 29.56 30.88 -78.30 -7.84 -4.29 -2.97 -16.18 -13.46 -79.58 45.34 -102.77 16.72 22.15 23.66 195.72 -88.54 -7.14 -7.143
P/OCF 52.40 — 43.06 28.70 30.04 — — — — — — — 35.59 — 16.54 21.69 26.87 123.06 — — —
EV/EBITDA 82.30 22.31 14.15 6.57 10.39 6.34 7.67 10.94 -28.36 30.03 7.50 7.23 5.80 10.83 19.55 -67.30 -15.16 -6.65 -5.81 -3.67 -3.671
EV/Revenue 2.27 3.90 3.99 2.32 3.86 2.21 1.76 1.07 1.02 0.66 1.52 1.89 1.76 2.21 1.49 1.49 0.77 1.59 2.11 1.99 1.992
EV/EBIT -236.40 25.62 14.92 6.78 10.63 6.48 7.94 12.21 -20.58 98.37 8.02 7.56 5.99 11.41 23.06 -40.78 -11.69 -6.17 -5.51 -3.53 -3.529
EV/FCF 46.12 -255.00 35.81 22.02 25.46 -62.70 -6.14 -2.68 -1.68 -6.75 -10.42 -62.87 34.86 -83.39 12.74 15.98 12.62 131.25 -64.33 -5.01 -5.010
Earnings Yield -0.3% 3.4% 12.6% 19.7% 12.9% 19.7% 7.4% 4.7% -2.0% 1.3% 7.5% 7.6% 9.8% 5.8% 2.3% -1.1% -5.9% -11.9% -11.9% -31.1% -31.15%
FCF Yield 1.6% -0.3% 2.3% 3.4% 3.2% -1.3% -12.8% -23.3% -33.6% -6.2% -7.4% -1.3% 2.2% -1.0% 6.0% 4.5% 4.2% 0.5% -1.1% -14.0% -14.00%
PEG Ratio snapshot only 0.032
Price/Tangible Book snapshot only 1.349
EV/Gross Profit snapshot only 5.474
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 5.13 5.24 4.72 5.01 7.83 6.92 7.96 9.13 8.77 11.76 9.85 11.63 10.52 9.64 8.06 8.14 7.38 9.72 7.27 8.71 8.707
Quick Ratio 4.70 4.94 4.50 4.84 7.47 6.46 6.93 7.18 6.24 8.94 7.16 8.91 8.22 7.93 6.58 6.21 5.27 6.63 4.45 4.44 4.441
Debt/Equity 0.02 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Net Debt/Equity -0.78 -0.55 -0.75 -0.72 -0.77 -0.51 -0.40 -0.42 -0.44 -0.46 -0.27 -0.35 -0.40 -0.38 -0.35 -0.41 -0.47 -0.44 -0.39 -0.40 -0.403
Debt/Assets 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.008
Debt/EBITDA 0.66 0.05 0.12 0.08 0.06 0.07 0.11 0.30 -0.93 1.47 0.12 0.07 0.05 0.07 0.22 -0.72 -0.30 -0.10 -0.05 -0.04 -0.036
Net Debt/EBITDA -30.47 -3.02 -3.28 -2.25 -2.21 -1.58 -2.13 -6.55 21.94 -41.88 -2.18 -1.92 -1.74 -2.52 -6.11 26.02 13.26 3.27 2.19 1.56 1.563
Interest Coverage — 4120.00 9165.00 7019.50 5374.67 7606.00 4171.50 2621.00 — — — — — — — — — — — — —
Equity Multiplier 1.24 1.24 1.27 1.25 1.16 1.18 1.15 1.13 1.13 1.10 1.12 1.10 1.11 1.11 1.14 1.13 1.14 1.10 1.13 1.12 1.119
Cash Ratio snapshot only 3.510
Cash to Debt snapshot only 44.274
FCF to Debt snapshot only -20.292
Defensive Interval snapshot only 313.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.72 0.90 0.85 0.99 1.11 1.00 0.70 0.55 0.47 0.44 0.57 0.66 0.75 0.72 0.67 0.64 0.60 0.48 0.40 0.35 0.350
Inventory Turnover 2.12 3.25 3.55 5.61 6.52 5.67 3.12 1.96 1.33 1.35 1.19 1.26 1.28 1.58 1.41 1.43 1.41 1.27 1.06 0.72 0.722
Receivables Turnover 7.07 3.40 4.70 5.50 7.75 3.03 3.23 3.09 3.49 1.75 1.96 2.65 3.46 2.75 2.10 2.43 2.71 2.13 2.09 2.45 2.448
Payables Turnover 5.77 4.96 5.32 3.45 3.78 3.11 2.89 2.65 2.33 2.49 2.91 4.00 4.05 4.57 3.72 4.15 3.86 3.83 2.72 2.61 2.610
DSO 52 107 78 66 47 121 113 118 104 209 187 138 105 133 174 150 135 171 175 149 149.1 days
DIO 172 112 103 65 56 64 117 186 274 271 306 289 284 231 259 256 259 288 344 506 505.8 days
DPO 63 74 69 106 96 117 126 138 156 147 125 91 90 80 98 88 94 95 134 140 139.8 days
Cash Conversion Cycle 161 146 112 26 7 68 104 166 222 333 367 336 300 283 335 318 300 364 384 515 515.1 days
Fixed Asset Turnover snapshot only 5.690
Operating Cycle snapshot only 654.9 days
Cash Velocity snapshot only 1.153
Capital Intensity snapshot only 2.357
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 47.1% 1.8% 2.1% 1.7% 1.3% 64.7% 9.6% -26.6% -43.9% -45.2% -15.8% 21.0% 65.6% 71.3% 24.7% 3.3% -13.8% -34.3% -42.9% -53.4% -53.39%
Net Income 97.3% 1.6% 5.9% 13.1% 149.0% 4.9% -70.5% -90.5% -1.0% -98.0% -26.0% 1.8% 11.4% 12.7% -61.3% -1.1% -1.3% -2.2% -5.3% -17.3% -17.26%
EPS 97.4% 1.6% 5.8% 13.0% 148.2% 4.9% -69.8% -90.3% -1.0% -98.0% -26.3% 1.8% 11.3% 12.6% -61.4% -1.1% -1.3% -2.2% -5.3% -17.1% -17.10%
FCF 2.4% 47.8% 2.7% 2.4% 6.2% -2.8% -3.8% -3.8% -3.3% -51.1% 57.3% 90.8% 1.1% 53.4% 2.0% 4.2% 3.6% 1.3% -1.2% -3.0% -2.99%
EBITDA 1.1% 1.8% 3.7% 12.1% 30.3% 2.3% -10.6% -79.8% -1.1% -96.6% -25.9% 2.2% 15.0% 15.0% -52.9% -1.1% -1.1% -1.8% -3.7% -10.5% -10.46%
Op. Income 87.5% 1.5% 2.6% 5.1% 18.0% 2.6% -13.1% -83.8% -1.1% -1.0% -31.7% 2.8% 7.7% 22.1% -53.0% -1.2% -1.5% -2.3% -5.7% -8.7% -8.69%
OCF Growth snapshot only -2.91%
Asset Growth snapshot only -29.89%
Equity Growth snapshot only -29.20%
Debt Growth snapshot only -42.35%
Shares Change snapshot only 0.87%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -8.3% 0.8% 9.8% 14.4% 18.3% 17.8% 17.0% 20.4% 24.3% 36.6% 42.4% 33.7% 29.3% 15.6% 4.8% -2.9% -7.1% -14.9% -15.7% -16.5% -16.48%
Revenue 5Y 41.8% 26.9% 22.3% 18.5% 18.5% 16.7% 11.1% 5.2% 0.1% -1.6% 4.1% 5.9% 9.0% 8.9% 10.9% 16.9% 22.3% 23.5% 15.5% 2.9% 2.86%
EPS 3Y — — — — — — — — — — — — — 17.7% -55.9% — — — — — —
EPS 5Y — 3.1% — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — 17.3% -56.1% — — — — — —
Net Income 5Y — 3.3% — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — 1.9% 21.7% -32.2% — — — — — —
EBITDA 5Y 57.2% 92.9% — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y -11.5% 0.1% 11.5% 16.7% 21.1% 19.1% 17.3% 20.1% 24.9% 38.9% 46.1% 35.4% 30.3% 12.9% -0.6% -10.6% -17.2% -26.3% -29.3% -29.9% -29.86%
Gross Profit 5Y 38.2% 24.9% 21.7% 18.3% 18.6% 16.5% 10.1% 3.7% -2.3% -3.6% 3.2% 4.8% 8.2% 6.8% 8.2% 13.0% 18.0% 17.7% 6.8% -6.3% -6.32%
Op. Income 3Y — — — — — — — — — — — — — 25.2% -34.7% — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — 30.5% — 6.6% -6.9% -31.5% — — — —
FCF 5Y — — — — — — — — — — — — — — -1.2% 26.4% 51.3% — — — —
OCF 3Y — — — — — — — — — — — — 33.0% — 6.2% -7.1% -34.9% — — — —
OCF 5Y — — — — — — — — — — — — — — -3.0% 20.5% 37.7% — — — —
Assets 3Y -7.7% -1.0% 16.9% 16.3% 15.2% 15.4% 18.2% 20.5% 22.2% 24.2% 29.3% 30.2% 32.7% 24.5% 3.7% 1.5% 2.1% -2.2% -1.2% -7.4% -7.43%
Assets 5Y 7.1% 11.2% 23.1% 24.5% 24.8% 24.7% 21.2% 20.9% 9.2% 10.1% 11.2% 10.2% 10.8% 11.0% 13.2% 14.6% 16.0% 13.6% 14.2% 9.4% 9.37%
Equity 3Y -7.7% -0.6% 16.0% 18.0% 20.7% 19.7% 23.5% 27.7% 29.7% 31.5% 35.8% 37.8% 38.0% 29.0% 7.7% 4.9% 2.8% 0.0% -0.6% -7.1% -7.12%
Book Value 3Y -13.1% -1.8% 14.8% 17.5% 20.1% 18.4% 24.0% 28.2% 30.2% 32.0% 36.2% 38.1% 38.4% 29.4% 8.3% 5.6% 3.4% 0.5% -1.0% -7.5% -7.52%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.21 0.18 0.25 0.24 0.27 0.29 0.31 0.24 0.13 0.10 0.25 0.22 0.22 0.20 0.66 0.51 0.38 0.24 0.22 0.09 0.091
Earnings Stability 0.06 0.03 0.35 0.40 0.44 0.52 0.40 0.28 0.20 0.24 0.26 0.21 0.21 0.17 0.05 0.02 0.01 0.01 0.16 0.32 0.320
Margin Stability 0.93 0.92 0.93 0.94 0.93 0.92 0.93 0.94 0.92 0.92 0.94 0.95 0.94 0.94 0.94 0.91 0.88 0.85 0.82 0.81 0.808
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Earnings Persistence 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.20 0.50 0.90 0.50 0.20 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness — — — — — 0.00 0.00 0.00 — 0.00 0.70 0.06 — 0.00 0.12 — — — — — —
ROE Trend 0.21 0.35 0.67 0.74 0.74 0.58 -0.01 -0.18 -0.30 -0.32 -0.23 -0.18 -0.10 -0.14 -0.08 -0.11 -0.13 -0.22 -0.23 -0.47 -0.475
Gross Margin Trend -0.01 0.03 0.06 0.07 0.09 0.08 0.03 -0.01 -0.05 -0.07 -0.05 -0.04 -0.02 -0.04 -0.06 -0.09 -0.12 -0.15 -0.20 -0.20 -0.198
FCF Margin Trend 0.13 0.07 0.11 0.17 0.12 0.01 -0.24 -0.35 -0.71 -0.07 -0.06 0.12 0.28 0.04 0.33 0.31 0.34 0.07 -0.02 -0.43 -0.429
Sustainable Growth Rate — 17.3% 67.7% 76.9% 78.9% 65.5% 14.2% 5.2% — 1.0% 9.5% 13.4% 18.9% 12.7% 3.5% — — — — — —
Internal Growth Rate — 15.8% 1.1% 1.5% 2.0% 1.2% 13.3% 4.6% — 0.9% 9.2% 13.7% 20.3% 13.0% 3.2% — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -6.28 -0.07 0.18 0.18 0.26 -0.06 -1.67 -4.88 16.66 -4.42 -0.93 -0.13 0.29 -0.13 2.60 -4.21 -0.63 -0.07 0.07 0.44 0.439
FCF/OCF 0.83 1.45 0.98 0.97 0.97 1.11 1.03 1.02 1.02 1.11 1.06 1.29 0.78 1.33 0.99 0.98 1.14 0.63 1.35 1.02 1.024
FCF/Net Income snapshot only 0.449
CapEx/Revenue 1.0% 0.5% 0.3% 0.3% 0.4% 0.4% 0.8% 1.0% 1.0% 0.9% 0.9% 0.7% 1.4% 0.7% 0.1% 0.2% 0.7% 0.7% 0.9% 0.9% 0.93%
CapEx/Depreciation snapshot only 0.422
Accruals Ratio -0.05 0.15 0.43 0.50 0.49 0.58 0.31 0.26 0.27 0.05 0.16 0.14 0.12 0.13 -0.05 -0.08 -0.08 -0.14 -0.13 -0.17 -0.174
Sloan Accruals snapshot only -0.257
Cash Flow Adequacy snapshot only -41.963
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — —
FCF Payout Ratio 0.0% — 0.0% 0.0% 0.0% — — — — — — — 0.0% — 0.0% 0.0% 0.0% 0.0% — — —
Total Payout Ratio — 0.1% 0.0% 4.0% 3.8% 12.4% 47.7% 83.6% — 5.6% 0.6% 0.4% 0.0% 0.0% 16.7% — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.8% 0.5% 2.4% 3.5% 3.9% 4.5% 0.1% 0.0% 0.0% 0.0% 0.0% 0.4% 0.4% 0.6% 0.5% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% -0.2% 0.5% 0.3% 2.1% 3.5% 3.8% 4.4% -0.0% 0.0% 0.0% -0.0% -0.1% 0.3% 0.3% 0.5% 0.5% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% -0.2% 0.5% 0.3% 2.1% 3.5% 3.8% 4.4% -0.0% 0.0% 0.0% -0.0% -0.1% 0.3% 0.3% 0.5% 0.5% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 0.97 0.94 0.92 0.87 0.73 0.77 1.20 0.75 0.72 0.70 0.72 0.74 0.52 1.72 0.64 0.80 0.68 1.22 1.219
Interest Burden (EBT/EBIT) 0.98 1.00 2.39 1.91 1.79 1.84 1.03 1.19 0.60 3.99 1.08 1.05 1.06 1.12 1.35 0.36 2.00 1.36 1.32 1.28 1.285
EBIT Margin -0.01 0.15 0.27 0.34 0.36 0.34 0.22 0.09 -0.05 0.01 0.19 0.25 0.29 0.19 0.06 -0.04 -0.07 -0.26 -0.38 -0.56 -0.565
Asset Turnover 0.72 0.90 0.85 0.99 1.11 1.00 0.70 0.55 0.47 0.44 0.57 0.66 0.75 0.72 0.67 0.64 0.60 0.48 0.40 0.35 0.350
Equity Multiplier 1.30 1.27 1.28 1.27 1.19 1.20 1.21 1.19 1.15 1.14 1.13 1.11 1.12 1.11 1.13 1.11 1.12 1.11 1.13 1.13 1.126
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.01 $0.25 $1.28 $1.51 $1.61 $1.46 $0.39 $0.15 $-0.06 $0.03 $0.29 $0.41 $0.57 $0.40 $0.11 $-0.05 $-0.18 $-0.47 $-0.47 $-0.94 $-0.94
Book Value/Share $1.25 $1.57 $2.55 $2.71 $2.84 $2.90 $2.85 $2.83 $2.74 $3.00 $3.14 $3.24 $3.31 $3.40 $3.24 $3.19 $3.14 $2.95 $2.77 $2.24 $2.24
Tangible Book/Share $1.24 $1.56 $2.54 $2.70 $2.84 $2.90 $2.85 $2.83 $2.74 $3.00 $3.14 $3.24 $3.31 $3.40 $3.24 $3.19 $3.14 $2.95 $2.77 $2.24 $2.24
Revenue/Share $1.16 $1.63 $2.06 $2.46 $2.68 $2.69 $2.32 $1.85 $1.53 $1.50 $1.94 $2.23 $2.53 $2.54 $2.41 $2.30 $2.18 $1.68 $1.37 $1.06 $1.06
FCF/Share $0.06 $-0.02 $0.23 $0.26 $0.41 $-0.09 $-0.66 $-0.73 $-0.93 $-0.15 $-0.28 $-0.07 $0.13 $-0.07 $0.28 $0.21 $0.13 $0.02 $-0.04 $-0.42 $-0.42
OCF/Share $0.07 $-0.02 $0.24 $0.27 $0.42 $-0.09 $-0.65 $-0.72 $-0.92 $-0.13 $-0.27 $-0.05 $0.16 $-0.05 $0.29 $0.22 $0.12 $0.03 $-0.03 $-0.41 $-0.41
Cash/Share $0.99 $0.87 $1.97 $2.03 $2.26 $1.54 $1.19 $1.23 $1.26 $1.42 $0.90 $1.16 $1.38 $1.34 $1.17 $1.36 $1.50 $1.35 $1.11 $0.92 $0.92
EBITDA/Share $0.03 $0.29 $0.58 $0.87 $0.99 $0.94 $0.53 $0.18 $-0.06 $0.03 $0.39 $0.58 $0.77 $0.52 $0.18 $-0.05 $-0.11 $-0.40 $-0.50 $-0.58 $-0.58
Debt/Share $0.02 $0.01 $0.07 $0.07 $0.06 $0.06 $0.06 $0.05 $0.05 $0.05 $0.05 $0.04 $0.04 $0.04 $0.04 $0.04 $0.03 $0.04 $0.02 $0.02 $0.02
Net Debt/Share $-0.97 $-0.86 $-1.90 $-1.96 $-2.20 $-1.48 $-1.13 $-1.18 $-1.21 $-1.37 $-0.86 $-1.12 $-1.34 $-1.30 $-1.13 $-1.32 $-1.46 $-1.31 $-1.09 $-0.90 $-0.90
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 7.197
Altman Z-Prime snapshot only 15.120
Piotroski F-Score 6 6 6 7 6 5 5 4 3 4 4 6 7 4 5 5 4 4 2 3 3
Beneish M-Score -0.91 -0.33 2.73 2.93 0.98 2.10 0.43 -0.77 -0.24 -2.39 -0.45 -1.00 -0.81 -1.34 -2.67 -2.81 -2.83 -3.60 -3.28 -5.26 -5.258
Ohlson O-Score snapshot only -4.490
ROIC (Greenblatt) snapshot only -27.13%
Net-Net WC snapshot only $2.02
EVA snapshot only $-12674240.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 79.81 88.27 95.92 96.07 96.24 89.83 88.40 88.99 74.47 73.35 86.01 86.48 93.28 86.39 93.42 81.50 80.95 82.37 74.63 74.72 74.722
Credit Grade snapshot only 6
Credit Trend snapshot only -6.774
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 71
Sector Credit Rank snapshot only 71

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms